St. John's Wort Extract 300 mg
Product analysis
St. John's Wort Extract 300 mg offers a standardized herbal option with preparation-specific mood evidence. It can substantially change the effects of medicines, which is a major consideration when deciding whether it is suitable.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Hypericin standardization gives useful detail about the extract. It does not establish that the preparation is interchangeable with those behind particular mood findings.
Ingredient Transparency100
The extract amount and standardization are stated. That makes the serving easier to identify, though standardized extracts can still differ.
Value For Money40
Value for the St. John's wort extract cannot be judged confidently.
Customer Satisfaction86
Customer feedback is generally favorable across thousands of ratings. The substantial review base gives useful satisfaction context without proving mood benefits or safety.
Product Focus55
Mood-related evidence applies to particular preparations and clinical groups, rather than routine mood enhancement in healthy adults. The serving is below the trial comparison, and substantial medicine interactions remain relevant.
- Format
Capsule - Container
- 240 Capsule(s)
- Per serving
- $0.05
- Also available
St. John's Wort Extract 300 mg$8.83- Customer rating
- 4.6 · 4,423 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
St. John's Wort aerial parts extract (Hypericin) | 300 mg |
How this ingredient is rated
Composition and Label Disclosure
Composition and Label Disclosure100
Explicit Label Detail
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- St John's wort for major depression.
- Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
- A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
- Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
- Complementary therapies for clinical depression: an overview of systematic reviews.
- Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
- Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
- Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
- Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
- Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.